Your browser doesn't support javascript.
loading
Activated protein C as disease-modifying therapy in antenatal preeclampsia: An open-label, single arm safety and efficacy trial.
von Dadelszen, Peter; Magee, Laura A; Benton, Samantha J; Hu, Yuxiang; Ansermino, J Mark; Carleton, Bruce; Carter, Cedric; Douglas, M Joanne; Janssen, Patricia A; Lee, Shoo K; Leung, Peter C K; Li, Jing; MacNab, Ying; Payne, Beth A; Peng, Gang; Rodger, Marc; Skoll, M Amanda; Synnes, Anne; Walley, Keith R; Russell, James A.
Afiliación
  • von Dadelszen P; School of Life Course Sciences, King's College London, London, UK. Electronic address: pvd@kcl.ac.uk.
  • Magee LA; School of Life Course Sciences, King's College London, London, UK.
  • Benton SJ; BC Children's Hospital Research Institute, Vancouver, Canada; Department of Obstetrics and Gynaecology, University of British Columbia, Vancouver, Canada.
  • Hu Y; BC Children's Hospital Research Institute, Vancouver, Canada; Department of Obstetrics and Gynaecology, University of British Columbia, Vancouver, Canada.
  • Ansermino JM; BC Children's Hospital Research Institute, Vancouver, Canada; Department of Anesthesia, Pharmacology and Therapeutics, University of British Columbia, Vancouver, Canada.
  • Carleton B; BC Children's Hospital Research Institute, Vancouver, Canada; Department of Pediatrics, University of British Columbia, Vancouver, Canada.
  • Carter C; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada.
  • Douglas MJ; BC Children's Hospital Research Institute, Vancouver, Canada; Department of Anesthesia, Pharmacology and Therapeutics, University of British Columbia, Vancouver, Canada.
  • Janssen PA; BC Children's Hospital Research Institute, Vancouver, Canada; School of Public and Population Health, University of British Columbia, Vancouver, Canada.
  • Lee SK; Department of Paediatrics, University of Toronto, Toronto, Canada.
  • Leung PCK; BC Children's Hospital Research Institute, Vancouver, Canada; Department of Obstetrics and Gynaecology, University of British Columbia, Vancouver, Canada.
  • Li J; BC Children's Hospital Research Institute, Vancouver, Canada; Department of Obstetrics and Gynaecology, University of British Columbia, Vancouver, Canada.
  • MacNab Y; BC Children's Hospital Research Institute, Vancouver, Canada; Department of Paediatrics, University of Toronto, Toronto, Canada.
  • Payne BA; BC Children's Hospital Research Institute, Vancouver, Canada; Department of Obstetrics and Gynaecology, University of British Columbia, Vancouver, Canada.
  • Peng G; BC Children's Hospital Research Institute, Vancouver, Canada; Department of Obstetrics and Gynaecology, University of British Columbia, Vancouver, Canada.
  • Rodger M; Department of Medicine, University of Ottawa, Ottawa, Canada.
  • Skoll MA; BC Children's Hospital Research Institute, Vancouver, Canada; Department of Obstetrics and Gynaecology, University of British Columbia, Vancouver, Canada.
  • Synnes A; BC Children's Hospital Research Institute, Vancouver, Canada; Department of Pediatrics, University of British Columbia, Vancouver, Canada.
  • Walley KR; Department of Medicine, University of British Columbia, Vancouver, Canada; Department of Critical Care Medicine, University of British Columbia, Vancouver, Canada.
  • Russell JA; Department of Medicine, University of British Columbia, Vancouver, Canada; Department of Critical Care Medicine, University of British Columbia, Vancouver, Canada.
Pregnancy Hypertens ; 13: 121-126, 2018 Jul.
Article en En | MEDLINE | ID: mdl-30177038

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Preeclampsia / Atención Prenatal / Proteína C / Fibrinolíticos Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Prognostic_studies Límite: Adult / Female / Humans / Pregnancy País/Región como asunto: America do norte Idioma: En Revista: Pregnancy Hypertens Año: 2018 Tipo del documento: Article Pais de publicación: Países Bajos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Preeclampsia / Atención Prenatal / Proteína C / Fibrinolíticos Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Prognostic_studies Límite: Adult / Female / Humans / Pregnancy País/Región como asunto: America do norte Idioma: En Revista: Pregnancy Hypertens Año: 2018 Tipo del documento: Article Pais de publicación: Países Bajos